The United States National Institutes of Health recruit candidates to participate in clinical trials aimed at better diagnosis and treatment of neuroendocrine tumor disease. The European Neuroendocrine Tumor Society is involved in ongoing clinical trials that concentrate on the therapeutic options in treating tumors of the foregut, midgut and hindgut. The following links provide lists of trials concerned with neuroendocrine tumors and also carcinoid disease.
- Clinical trials on carcinoid
-
-
CLARINET STUDY: Clinical trial on non functioning entero-pancreatic endocrine tumors. Inclusion ongoing (200 randomized patients required). Primary endpoint: Time to either disease progression or death within 96 weeks. For further details, please click here: Trials sponsored by Ipsen
-
|
|
|